Annual CAPEX:
$498.00M-$28.00M(-5.32%)Summary
- As of today, TEVA annual capital expenditures is $498.00 million, with the most recent change of -$28.00 million (-5.32%) on December 31, 2024.
- During the last 3 years, TEVA annual CAPEX has fallen by -$64.00 million (-11.39%).
- TEVA annual CAPEX is now -54.72% below its all-time high of $1.10 billion, reached on December 31, 2012.
Performance
TEVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$97.76M-$29.24M(-23.03%)Summary
- As of today, TEVA quarterly capital expenditures is $97.76 million, with the most recent change of -$29.24 million (-23.03%) on June 30, 2025.
- Over the past year, TEVA quarterly CAPEX has increased by +$758.10 thousand (+0.78%).
- TEVA quarterly CAPEX is now -70.64% below its all-time high of $333.00 million, reached on December 31, 2016.
Performance
TEVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$501.76M+$758.10K(+0.15%)Summary
- As of today, TEVA TTM capital expenditures is $501.76 million, with the most recent change of +$758.10 thousand (+0.15%) on June 30, 2025.
- Over the past year, TEVA TTM CAPEX has increased by +$12.76 million (+2.61%).
- TEVA TTM CAPEX is now -54.80% below its all-time high of $1.11 billion, reached on March 31, 2013.
Performance
TEVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -5.3% | +0.8% | +2.6% |
| 3Y3 Years | -11.4% | -23.0% | -13.9% |
| 5Y5 Years | -5.1% | -25.4% | -3.7% |
TEVA CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.4% | at low | -34.4% | +0.8% | -10.2% | +2.8% |
| 5Y | 5-Year | -13.8% | at low | -44.5% | +0.8% | -16.4% | +2.8% |
| All-Time | All-Time | -54.7% | +2133.2% | -70.6% | +318.1% | -54.8% | +2045.8% |
TEVA CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $97.76M(-23.0%) | $501.76M(+0.2%) |
| Mar 2025 | - | $127.00M(-1.6%) | $501.00M(+0.6%) |
| Dec 2024 | $498.00M(-5.3%) | $129.00M(-12.8%) | $498.00M(+2.0%) |
| Sep 2024 | - | $148.00M(+52.6%) | $488.00M(-0.2%) |
| Jun 2024 | - | $97.00M(-21.8%) | $489.00M(-4.3%) |
| Mar 2024 | - | $124.00M(+4.2%) | $511.00M(-2.9%) |
| Dec 2023 | $526.00M(-4.0%) | $119.00M(-20.1%) | $526.00M(-4.2%) |
| Sep 2023 | - | $149.00M(+25.2%) | $549.00M(+5.2%) |
| Jun 2023 | - | $119.00M(-14.4%) | $522.00M(-1.5%) |
| Mar 2023 | - | $139.00M(-2.1%) | $530.00M(-3.3%) |
| Dec 2022 | $548.00M(-2.5%) | $142.00M(+16.4%) | $548.00M(-2.0%) |
| Sep 2022 | - | $122.00M(-3.9%) | $559.00M(-4.1%) |
| Jun 2022 | - | $127.00M(-19.1%) | $583.00M(+2.5%) |
| Mar 2022 | - | $157.00M(+2.6%) | $569.00M(+1.2%) |
| Dec 2021 | $562.00M(-2.8%) | $153.00M(+4.8%) | $562.00M(-3.9%) |
| Sep 2021 | - | $146.00M(+29.2%) | $585.00M(+0.5%) |
| Jun 2021 | - | $113.00M(-24.7%) | $582.00M(-3.0%) |
| Mar 2021 | - | $150.00M(-14.8%) | $600.00M(+3.8%) |
| Dec 2020 | $578.00M(+10.1%) | $176.00M(+23.1%) | $578.00M(+10.9%) |
| Sep 2020 | - | $143.00M(+9.2%) | $521.00M(-4.8%) |
| Jun 2020 | - | $131.00M(+2.3%) | $547.00M(+3.6%) |
| Mar 2020 | - | $128.00M(+7.6%) | $528.00M(+0.6%) |
| Dec 2019 | $525.00M(-19.4%) | $119.00M(-29.6%) | $525.00M(-15.2%) |
| Sep 2019 | - | $169.00M(+50.9%) | $619.00M(+5.1%) |
| Jun 2019 | - | $112.00M(-10.4%) | $589.00M(-3.9%) |
| Mar 2019 | - | $125.00M(-41.3%) | $613.00M(-5.8%) |
| Dec 2018 | $651.00M(-25.5%) | $213.00M(+53.2%) | $651.00M(-7.7%) |
| Sep 2018 | - | $139.00M(+2.2%) | $705.00M(-9.4%) |
| Jun 2018 | - | $136.00M(-16.6%) | $778.00M(-6.8%) |
| Mar 2018 | - | $163.00M(-39.0%) | $835.00M(-4.5%) |
| Dec 2017 | $874.00M(-3.3%) | $267.00M(+25.9%) | $874.00M(-7.0%) |
| Sep 2017 | - | $212.00M(+9.8%) | $940.00M(-0.9%) |
| Jun 2017 | - | $193.00M(-4.5%) | $949.00M(+1.9%) |
| Mar 2017 | - | $202.00M(-39.3%) | $931.00M(+3.3%) |
| Dec 2016 | $904.04M(+17.1%) | $333.00M(+50.7%) | $901.00M(+10.4%) |
| Sep 2016 | - | $221.00M(+26.3%) | $816.00M(+6.7%) |
| Jun 2016 | - | $175.00M(+1.7%) | $765.00M(+0.8%) |
| Mar 2016 | - | $172.00M(-30.6%) | $759.00M(-1.7%) |
| Dec 2015 | $772.00M(-16.9%) | $248.00M(+45.9%) | $772.00M(-6.3%) |
| Sep 2015 | - | $170.00M(+0.6%) | $824.00M(-4.8%) |
| Jun 2015 | - | $169.00M(-8.6%) | $866.00M(-2.6%) |
| Mar 2015 | - | $185.00M(-38.3%) | $889.00M(-4.3%) |
| Dec 2014 | $929.00M(-9.9%) | $300.00M(+41.5%) | $929.00M(-0.6%) |
| Sep 2014 | - | $212.00M(+10.4%) | $934.69M(-0.9%) |
| Jun 2014 | - | $192.00M(-14.7%) | $943.13M(-4.1%) |
| Mar 2014 | - | $225.00M(-26.4%) | $983.51M(-4.6%) |
| Dec 2013 | $1.03B(-6.3%) | $305.69M(+38.7%) | $1.03B(-2.2%) |
| Sep 2013 | - | $220.44M(-5.1%) | $1.05B(-3.1%) |
| Jun 2013 | - | $232.38M(-14.6%) | $1.09B(-2.1%) |
| Mar 2013 | - | $272.12M(-17.2%) | $1.11B(+0.9%) |
| Dec 2012 | $1.10B | $328.70M(+29.6%) | $1.10B(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | $253.68M(-0.7%) | $1.08B(-1.3%) |
| Jun 2012 | - | $255.54M(-2.5%) | $1.10B(+2.6%) |
| Mar 2012 | - | $262.02M(-16.1%) | $1.07B(+2.2%) |
| Dec 2011 | $1.05B(+47.7%) | $312.38M(+16.7%) | $1.05B(+8.1%) |
| Sep 2011 | - | $267.70M(+17.5%) | $968.61M(+10.9%) |
| Jun 2011 | - | $227.78M(-4.8%) | $873.49M(+11.5%) |
| Mar 2011 | - | $239.18M(+2.2%) | $783.11M(+10.5%) |
| Dec 2010 | $708.81M(-1.2%) | $233.96M(+35.6%) | $708.81M(+2.0%) |
| Sep 2010 | - | $172.58M(+25.6%) | $695.14M(-1.8%) |
| Jun 2010 | - | $137.40M(-16.7%) | $707.71M(-1.5%) |
| Mar 2010 | - | $164.87M(-25.2%) | $718.60M(+0.3%) |
| Dec 2009 | $717.60M(+5.9%) | $220.29M(+19.0%) | $716.75M(+44.4%) |
| Sep 2009 | - | $185.15M(+24.9%) | $496.46M(+59.5%) |
| Jun 2009 | - | $148.29M(-9.0%) | $311.31M(-8.1%) |
| Mar 2009 | - | $163.02M(-7.3%) | $338.91M(-42.1%) |
| Dec 2008 | $677.40M(+25.7%) | - | - |
| Jun 2008 | - | $175.89M(+24.7%) | $585.36M(+11.6%) |
| Mar 2008 | - | $141.10M(-2.2%) | $524.59M(-2.7%) |
| Dec 2007 | $538.71M(+38.8%) | $144.25M(+16.2%) | $539.24M(+3.1%) |
| Sep 2007 | - | $124.12M(+7.8%) | $523.23M(+5.5%) |
| Jun 2007 | - | $115.12M(-26.1%) | $495.85M(+5.2%) |
| Mar 2007 | - | $155.75M(+21.5%) | $471.29M(+21.4%) |
| Dec 2006 | $388.06M(+16.1%) | $128.24M(+32.6%) | $388.06M(+13.0%) |
| Sep 2006 | - | $96.74M(+6.8%) | $343.37M(+4.4%) |
| Jun 2006 | - | $90.56M(+24.9%) | $328.83M(+8.0%) |
| Mar 2006 | - | $72.52M(-13.2%) | $304.39M(-2.0%) |
| Dec 2005 | $334.31M(-1.3%) | $83.55M(+1.6%) | $310.76M(-4.9%) |
| Sep 2005 | - | $82.20M(+24.3%) | $326.62M(+2.0%) |
| Jun 2005 | - | $66.12M(-16.2%) | $320.29M(-1.8%) |
| Mar 2005 | - | $78.89M(-20.6%) | $326.08M(+4.8%) |
| Dec 2004 | $338.66M(+50.6%) | $99.42M(+31.0%) | $311.15M(+12.9%) |
| Sep 2004 | - | $75.87M(+5.5%) | $275.62M(+38.0%) |
| Jun 2004 | - | $71.91M(+12.4%) | $199.75M(+56.2%) |
| Mar 2004 | - | $63.96M(+0.1%) | $127.85M(+100.1%) |
| Dec 2003 | $224.84M(+20.9%) | $63.89M(+67.4%) | $63.89M(-54.3%) |
| Dec 2002 | $185.95M(+38.7%) | - | - |
| Jun 2002 | - | $38.17M(+39.3%) | $139.92M(+1.3%) |
| Mar 2002 | - | $27.40M(-36.4%) | $138.08M(+3.0%) |
| Dec 2001 | $134.07M(+19.8%) | $43.07M(+37.7%) | $134.07M(+47.3%) |
| Sep 2001 | - | $31.28M(-13.9%) | $91.00M(+52.4%) |
| Jun 2001 | - | $36.34M(+55.4%) | $59.72M(+155.4%) |
| Mar 2001 | - | $23.38M | $23.38M |
| Dec 2000 | $111.94M(-64.3%) | - | - |
| Dec 1999 | $313.79M(+38.4%) | - | - |
| Dec 1998 | $226.73M(+231.3%) | - | - |
| Dec 1997 | $68.44M(-19.7%) | - | - |
| Dec 1996 | $85.25M(+5.8%) | - | - |
| Dec 1995 | $80.55M(+13.3%) | - | - |
| Dec 1994 | $71.10M(+76.2%) | - | - |
| Dec 1993 | $40.35M(+24.7%) | - | - |
| Dec 1992 | $32.35M(+45.1%) | - | - |
| Dec 1991 | $22.30M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual capital expenditures?
- What is the all-time high annual CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
- What is the all-time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
What is Teva Pharmaceutical Industries Limited annual capital expenditures?
The current annual CAPEX of TEVA is $498.00M
What is the all-time high annual CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual capital expenditures is $1.10B
What is Teva Pharmaceutical Industries Limited annual CAPEX year-on-year change?
Over the past year, TEVA annual capital expenditures has changed by -$28.00M (-5.32%)
What is Teva Pharmaceutical Industries Limited quarterly capital expenditures?
The current quarterly CAPEX of TEVA is $97.76M
What is the all-time high quarterly CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly capital expenditures is $333.00M
What is Teva Pharmaceutical Industries Limited quarterly CAPEX year-on-year change?
Over the past year, TEVA quarterly capital expenditures has changed by +$758.10K (+0.78%)
What is Teva Pharmaceutical Industries Limited TTM capital expenditures?
The current TTM CAPEX of TEVA is $501.76M
What is the all-time high TTM CAPEX for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM capital expenditures is $1.11B
What is Teva Pharmaceutical Industries Limited TTM CAPEX year-on-year change?
Over the past year, TEVA TTM capital expenditures has changed by +$12.76M (+2.61%)